Genabio Diagnostics is transforming testing for companies and their employees by offering a low-cost, easy-to-use, point-of-care diagnostic platform for infectious diseases and drug abuse testing. Genabio’s testing system is designed to provide individuals access to cutting-edge molecular and serological testing and real-time data integration for rapid testing and disease management. With an initial focus on drug abuse screening using oral fluid samples, Genabio provides a revolutionary solution for law enforcement, clinical practice, and workforce screening on a variety of common drugs. With the expansion of our leading technology on infectious diseases, Genabio’s diagnostic platform can be adapted to detect a wide range of life-threatening diseases including respiratory infections, sex transmitted diseases, and wound infections. Genabio believes affordable access to real-time, at-home results, will transform the way people look at diagnostics and disease management post the COVID-19 era.